Leuko Revenue and Competitors
Estimated Revenue & Valuation
- Leuko's estimated annual revenue is currently $4.3M per year.
- Leuko's estimated revenue per employee is $251,000
Employee Data
- Leuko has 17 Employees.
- Leuko grew their employee count by 0% last year.
Leuko's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder and CEO | Reveal Email/Phone |
2 | Co-Founder and CEO | Reveal Email/Phone |
3 | Chief Data Scientist | Reveal Email/Phone |
4 | Cofounder & CTO | Reveal Email/Phone |
5 | Cofounder & CTO | Reveal Email/Phone |
6 | Chief Medical Officer | Reveal Email/Phone |
7 | Cofounder | Chief Medical Officer | Reveal Email/Phone |
8 | Chief Medical Officer | Reveal Email/Phone |
9 | Hardware Engineer | Reveal Email/Phone |
10 | Product Software Engineer | Reveal Email/Phone |
Leuko Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $11M | 44 | 13% | N/A | N/A |
#2 | $11M | 44 | 29% | N/A | N/A |
#3 | $4.3M | 17 | 0% | N/A | N/A |
#4 | $3.8M | 15 | -29% | N/A | N/A |
#5 | $5630M | 9122 | -11% | $450M | N/A |
#6 | $4.3M | 17 | 0% | N/A | N/A |
#7 | $4M | 16 | -72% | $23.5M | N/A |
#8 | $44.4M | 177 | 9% | N/A | N/A |
#9 | $45.7M | 182 | 0% | N/A | N/A |
#10 | $15M | 79 | 8% | $105.2M | N/A |
What Is Leuko?
Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is a first-line indicator for various medically-relevant situations, ranging from chemotherapy management to the detection of life threatening infections worldwide. This test is currently invasive and not readily accessible - it requires patient travel, blood draws and laboratory infrastructure. Based on MIT research, Leuko is re-imagining the way to perform these tests without extracting blood and in a portable device.
keywords:N/A
N/A
Total Funding
17
Number of Employees
$4.3M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Leuko News
Another company Leuko, based in Spain, is targeting cancer patients with a device that claims to be the first device for non-invasive white...
Another company Leuko, based in Spain, is targeting cancer patients with a device that claims to be the first device for non-invasive white...
... GlaxoSmithKline, Guardant Health, Leuko, Lilly, Medica Scientia Innovation Research, Menarini, Merck Sharp & Dohme, Nektar Therapeutics,...
... GlaxoSmithKline, Guardant Health, Leuko, Lilly, Medica Scientia Innovation Research, Menarini, Merck Sharp & Dohme, Nektar Therapeutics,...
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.8M | 17 | N/A | N/A |
#2 | $2.1M | 17 | N/A | N/A |
#3 | $1.5M | 17 | N/A | N/A |
#4 | $0.5M | 17 | 6% | $3.7M |
#5 | $2.1M | 17 | N/A | N/A |